|Hospital:||University of Texas, M. D. Anderson Cancer Center|
|Patients: This Phase I trial involved 49 patients with a variety of different cancers. Three of the 49 patients had mesothelioma.|
Treatment: The treatment consisted of an extract from green tea (Camellia sinensis).
Toxicity: Toxicities included grade 3 constipation, and grade 2 palpitations, fatigue, vomiting, pain, and cough.
Results: The median duration of therapy was only two months. There were no major responses and overall survival was not discussed.
Support: Ito En, Ltd provided research support. This company markets green tea extract.
Correspondence: Katherine M.W. Pisters, MD